ABITEC Corporation and DKSH Announce Specialty Lipid Distribution Agreement
US ingredients conglomerate ABITEC Corporation signs exclusive agreement with DKSH to distribute their specialty lipids into the pharmaceutical, nutritional, and specialty markets in Thailand, Spain and Portugal.
Columbus, OH, July 30, 2018 - ABITEC Corporation, a global manufacturer of specialty lipids, has executed a multi-year agreement with distribution partner DKSH to market and sell its ingredients into select markets. DKSH who is a leading provider of Market Expansion Services with a focus on Asia will exclusively distribute ABITEC’s lipid-based excipients and nutritional supplements in Thailand, Spain and Portugal. The agreement strengthens an already existing relationship between the two companies and aims to help grow and expand their presence in these emerging markets.
Damon Dalrymple, Managing Director Europe and Asia, ABITEC, states: "ABITEC's relationship with DKSH has continued to evolve over the last few years, and we are very pleased to formalize this partnership with them. DKSH has extensive knowledge and insight into these chosen markets and possesses a top-notch logistic infrastructure that will allow ABITEC a strategic advantage in delivering ingredient solutions globally. Together, ABITEC and DKSH will have the opportunity to expand their presence in emerging markets and serve their customers with high-quality products and technical expertise.”
Tanja Schaffer, Vice President, Pharmaceutical Industry, DKSH, commented: “We are delighted to partner with ABITEC in multiple countries across Europe and in Asia. Their innovative lipid solutions strengthen our existing portfolio and will provide exciting new opportunities in the field of formulation development for our loyal customer base in some of our key pharmaceutical markets.”
ABITEC’s trademarked specialty lipids include Capmul, Captex, Caprol, Acconon, Sterotex, Nutri Sperse, Hydro-Kote and Pureco. Their application area varies from pharmaceutical, nutritional and cosmetic products, to the manufacturing of foams, creams, ointments and lotions. The range is produced in ISO-certified facilities in accordance with cGMP and IPEC guidelines.
About ABITEC Corporation
ABITEC Corporation is part of ABF Ingredients and is headquartered in Columbus, Ohio, US with two manufacturing sites in the Midwest. ABITEC specializes in the manufacturing and distribution of specialty lipid ingredients for use in the pharmaceutical, nutraceutical, and specialty chemical markets. In addition, ABITEC offers contract and toll manufacturing services for customers looking to develop and manufacture new oleochemical molecules, blend, or toll-manufacture an established product.
About ABF Ingredients
ABF Ingredients is a division of Associated British Foods that focuses on high value ingredients for both food and non-food areas and comprises a range of ingredient companies which include AB Enzymes, Ohly, PGP International, and SPI Pharma. The group has established strong market positions in cereal specialties, enzymes, esters, extruded ingredients, specialty lipids, specialty powders, specialty flours, yeast extracts worldwide.
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets. Publicly listed on the SIX Swiss Exchange since 2012, DKSH is a global company headquartered in Zurich. With 825 business locations in 37 countries – 800 of them in Asia – and 31,970 specialized staff, DKSH generated net sales of CHF 11.0 billion in 2017. DKSH was founded in 1865. With strong Swiss heritage, the company has a long tradition of doing business in and with Asia and is deeply rooted in communities and businesses across Asia Pacific.
For further information, please contact:
Manager: Marketing Research and Communications
614-429-6453 | [email protected]
DKSH Performance Materials
Manager, Group Communications, Performance Materials
Phone +44 20 8879 5500
This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "comfortable with," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.